Bridging industry and academia to improve community health
One of the great things about a life in science is that there's a variety of career options throughout industry, academia and other sectors. Although this column normally focuses on only one such category, industry, there are many jobs that bridge them and don’t clearly belong to any one sector.
This week, I talked with , professor at and founding director of the . Dodani’s career has spanned the medical, research and healthcare fields. She talked to me about her background and career and highlighted yet another way scientists can be involved in the healthcare industry.
The path to founding director
Dodani started her scientific education in Pakistan, where she earned her medical degree from the . She then crossed the globe, coming to the U.S. for specialized training in cardiology. She next focused on training in research, earning her master's in clinical epidemiology at in Canada and a Ph.D. at the , where she earned two .
From there, Dodani served in different roles at several institutions. In addition to her research, she started working on using healthcare analytics tools to create high-performing and sustainable health systems. She describes herself as “an administrator that builds research infrastructures and strengthens clinical infrastructures.”
Dodani was the founding director of the Center for Outcome Research and Education at the . She also served as an associate professor at the and was affiliated with the 's .
Dodani was asked to found and direct HADSI in Norfolk, Virginia, in 2017. “I was honored to receive the invitation,” she said. “We built HADSI from scratch, and now we have 10 faculty and staff members — we’ve come a long way.”
So what is HADSI?
HADSI offers data analytics services and research support to help advance the healthcare community. The institute was founded as a partnership between , the largest healthcare system in the Virginia region, and EVMS, an academic research and medical school.
“HADSI functions as a bridge between these two partner institutes,” Dodani said. “This way, we are able to take advantage of Sentara Healthcare data and provide (the system with) physicians and researchers to better understand how to improve patient outcomes.”
HADSI supports research by offering research analytical services, grant-writing support, and other programs aimed at helping researchers succeed. Dodani said there are only 18 to 20 institutions similar to HADSI in the U.S., yet HADSI sits at a unique intersection of the academia and the medical and healthcare industries.
For Dodani, one of the driving motivators to establishing an institute like HADSI was to improve the health of the surrounding community.
“Collaborative efforts between academia, industry and other healthcare partners can improve the health of people,” she said. “This is especially important in light of the current pandemic, where many in the community are scared and have experienced a stressful time.”
A nationally recognized leader
Dodani has received national recognition for her work on bridging healthcare industry and academia, in addition to her efforts to improve health disparity research. Last month, she was selected to serve as part of a to help inform the White House about COVID-19 policies. The task force is run by the , a nonprofit that works with many White House officials on improving health policies.
Dodani said she was honored to receive the invitation, but it didn’t come as a big surprise — she’s been part of similar initiatives before.
In 2016, she was invited by President Barack Obama to attend on clean energy at lithium-ion battery plant in Jacksonville. That same year, she also was invited by the White House to participate in the " in Washington, D.C. During the summit, she met with the first lady, Michelle Obama, and shared with her some of the health issues that women of color are facing.
As the founding director and leader of an institute like HADSI, and given her experience in related positions, Dodani has paved the way for similar-minded researchers to follow in her footsteps. In recognition of her accomplishments, she has been a keynote speaker at the annual conference for the past two years.
“Last year, I presented my journey from a developing country to a developed country, and about being a female minority in the industry with a disability,” she says. (Dodani had polio as a child.)
This year, her message focused on resilience in the face of adversity.
“There are many challenges that women may face, and resiliency is key to overcoming them,” Dodani said. “Also, with these challenges comes a lot of opportunity, and resiliency will also help you harness them.” This message can be applied regardless of setting and is a nice reminder for scientists regardless of their field.
I have to add that Dodani was one of the friendliest people I have had the pleasure of interviewing. I could hear her passion for her work in her voice, and she was more than happy to share her experiences.
Dodani’s current and past positions highlight some of the less well-recognized paths scientists can take if they are interested in careers in the healthcare industry and research. Stay tuned for more insights into industry careers soon!
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreFeatured jobs
from the
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Careers
Careers highlights or most popular articles
Upcoming opportunities
Just added: Register for ASBMB's virtual session on thriving in challenging academic or work environments.
Who decides when a grad student graduates?
Ph.D. programs often don’t have a set timeline. Students continue with their research until their thesis is done, which is where variability comes into play.
Upcoming opportunities
Submit an abstract for ASBMB's meeting on ferroptosis!
Join the pioneers of ferroptosis at cell death conference
Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.
A brief history of the performance review
Performance reviews are a widely accepted practice across all industries — including pharma and biotech. Where did the practice come from, and why do companies continue to require them?
Upcoming opportunities
Save the date for ASBMB's in-person conferences on gene expression and O-GlcNAcylation in health and disease.